Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Alector, Inc. Alector Presents Baseline Characteristics for INVOKE-2 Phase 2 Clinical Trial of AL002 at the Alzheimer's Association International Conference® 2024 (AAIC®) July 28, 2024 From Alector, Inc. Via GlobeNewswire Tickers ABBV ALEC Alector to Present Data on Pipeline Focus Areas at the Alzheimer's Association International Conference® (AAIC®) 2024 July 23, 2024 From Alector, Inc. Via GlobeNewswire Tickers ALEC Alector to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference June 20, 2024 From Alector, Inc. Via GlobeNewswire Tickers ALEC Alector to Host Virtual Research and Development Event Highlighting Alector Brain Carrier Blood-Brain Barrier Technology Platform June 10, 2024 From Alector, Inc. Via GlobeNewswire Tickers ALEC Alector to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference June 03, 2024 From Alector, Inc. Via GlobeNewswire Tickers ALEC Alector to Participate in Upcoming Healthcare Conferences May 09, 2024 From Alector, Inc. Via GlobeNewswire Tickers ALEC Alector Reports First Quarter 2024 Financial Results and Provides Business Update May 08, 2024 From Alector, Inc. Via GlobeNewswire Tickers ALEC Alector to Participate in Upcoming Healthcare Conferences February 28, 2024 From Alector, Inc. Via GlobeNewswire Tickers ALEC Alector Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update February 27, 2024 From Alector, Inc. Via GlobeNewswire Tickers ALEC Alector to Host Fourth Quarter and Full-Year 2023 Earnings Call February 20, 2024 From Alector, Inc. Via GlobeNewswire Tickers ALEC Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer’s Disease February 08, 2024 From Alector, Inc. Via GlobeNewswire Tickers ALEC GSK FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN) February 07, 2024 From Alector, Inc. Via GlobeNewswire Tickers ALEC GSK Alector Announces Closing of Public Offering January 19, 2024 From Alector, Inc. Via GlobeNewswire Tickers ALEC Alector Announces Pricing of Public Offering of Common Stock January 17, 2024 From Alector, Inc. Via GlobeNewswire Tickers ALEC Alector Announces Proposed Public Offering of Common Stock January 16, 2024 From Alector, Inc. Via GlobeNewswire Tickers ALEC Alector to Host Two Virtual Research and Development Events Highlighting TREM2 and Progranulin Programs November 28, 2023 From Alector, Inc. Via GlobeNewswire Tickers ALEC Alector to Participate in the Stifel Healthcare Conference November 08, 2023 From Alector, Inc. Via GlobeNewswire Tickers ALEC Alector Reports Third Quarter 2023 Financial Results and Provides Business Update November 07, 2023 From Alector, Inc. Via GlobeNewswire Tickers ALEC Alector Announces Achievement of Target Enrollment in the Pivotal INFRONT-3 Phase 3 Clinical Trial of Latozinemab in Individuals with Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN) October 27, 2023 From Alector, Inc. Via GlobeNewswire Tickers ALEC GSK Alector Announces Completion of Enrollment in the INVOKE-2 Phase 2 Clinical Trial of AL002, a TREM2 Monoclonal Antibody, in Individuals With Early Alzheimer’s Disease September 07, 2023 From Alector, Inc. Via GlobeNewswire Tickers ABBV ALEC Alector to Participate in Upcoming Healthcare Conferences August 31, 2023 From Alector, Inc. Via GlobeNewswire Tickers ALEC Alector Reports Second Quarter 2023 Financial Results and Provides Business Update August 03, 2023 From Alector, Inc. Via GlobeNewswire Tickers ALEC Alector to Host Mid-Year Earnings Conference Call July 27, 2023 From Alector, Inc. Via GlobeNewswire Tickers ALEC Alector to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference June 06, 2023 From Alector, Inc. Via GlobeNewswire Tickers ALEC Alector Reports First Quarter 2023 Financial Results and Provides Business Update May 04, 2023 From Alector, Inc. Via GlobeNewswire Tickers ALEC Alector to Participate in the BofA Securities 2023 Healthcare Conference May 02, 2023 From Alector, Inc. Via GlobeNewswire Tickers ALEC Alector to Participate in Upcoming Healthcare Conferences March 01, 2023 From Alector, Inc. Via GlobeNewswire Tickers ALEC Alector Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update February 28, 2023 From Alector, Inc. Via GlobeNewswire Tickers ALEC Alector Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) December 08, 2022 From Alector, Inc. Via GlobeNewswire Tickers ALEC Alector Presents Results from First-in-Human Phase 1 Study of AL101 for the Treatment of Neurodegenerative Diseases November 29, 2022 From Alector, Inc. Via GlobeNewswire Tickers ALEC Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.